Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

1.

Plasma autoantibodies against heat shock protein 70, enolase 1 and ribonuclease/angiogenin inhibitor 1 as potential biomarkers for cholangiocarcinoma.

Rucksaken R, Pairojkul C, Pinlaor P, Khuntikeo N, Roytrakul S, Selmi C, Pinlaor S.

PLoS One. 2014 Jul 24;9(7):e103259. doi: 10.1371/journal.pone.0103259. eCollection 2014.

PMID:
25058392
[PubMed - in process]
Free PMC Article
2.

Serum adhesion molecule-1 (ICAM-1) as a potential prognostic marker for cholangiocarcinoma patients.

Janan M, Proungvitaya S, Limpaiboon T, Proungvitaya T, Roytrakul S, Wongkham C, Jearanaikoon P, Chur-in S, Wongkham S.

Asian Pac J Cancer Prev. 2012;13 Suppl:107-14.

PMID:
23480771
[PubMed - in process]
Free Article
3.

Proteomics-based identification of autoantibody against heat shock protein 70 as a diagnostic marker in esophageal squamous cell carcinoma.

Fujita Y, Nakanishi T, Miyamoto Y, Hiramatsu M, Mabuchi H, Miyamoto A, Shimizu A, Takubo T, Tanigawa N.

Cancer Lett. 2008 May 18;263(2):280-90. doi: 10.1016/j.canlet.2008.01.013. Epub 2008 Mar 10.

PMID:
18334280
[PubMed - indexed for MEDLINE]
4.

Increase of exostosin 1 in plasma as a potential biomarker for opisthorchiasis-associated cholangiocarcinoma.

Khoontawad J, Hongsrichan N, Chamgramol Y, Pinlaor P, Wongkham C, Yongvanit P, Pairojkul C, Khuntikeo N, Roytrakul S, Boonmars T, Pinlaor S.

Tumour Biol. 2014 Feb;35(2):1029-39. doi: 10.1007/s13277-013-1137-9. Epub 2013 Sep 10.

PMID:
24018821
[PubMed - indexed for MEDLINE]
5.

PRKAR1A overexpression is associated with increased ECPKA autoantibody in liver fluke-associated cholangiocarcinoma: application for assessment of the risk group.

Loilome W, Yooyuen S, Namwat N, Sithithaworn P, Puapairoj A, Kano J, Noguchi M, Miwa M, Yongvanit P.

Tumour Biol. 2012 Dec;33(6):2289-98. doi: 10.1007/s13277-012-0491-3. Epub 2012 Aug 26.

PMID:
22922884
[PubMed - indexed for MEDLINE]
6.

Anti-alpha-enolase autoantibodies are down-regulated in advanced cancer patients.

Shih NY, Lai HL, Chang GC, Lin HC, Wu YC, Liu JM, Liu KJ, Tseng SW.

Jpn J Clin Oncol. 2010 Jul;40(7):663-9. doi: 10.1093/jjco/hyq028. Epub 2010 Apr 15.

PMID:
20395242
[PubMed - indexed for MEDLINE]
Free Article
7.

A prospective proteomic-based study for identifying potential biomarkers for the diagnosis of cholangiocarcinoma.

Shi Y, Deng X, Zhan Q, Shen B, Jin X, Zhu Z, Chen H, Li H, Peng C.

J Gastrointest Surg. 2013 Sep;17(9):1584-91. doi: 10.1007/s11605-013-2182-9. Epub 2013 Jul 19.

PMID:
23868055
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Increased activation of PI3K/AKT signaling pathway is associated with cholangiocarcinoma metastasis and PI3K/mTOR inhibition presents a possible therapeutic strategy.

Yothaisong S, Dokduang H, Techasen A, Namwat N, Yongvanit P, Bhudhisawasdi V, Puapairoj A, Riggins GJ, Loilome W.

Tumour Biol. 2013 Dec;34(6):3637-48. doi: 10.1007/s13277-013-0945-2. Epub 2013 Jul 6.

PMID:
23832540
[PubMed - indexed for MEDLINE]
9.

Inflammation-induced protein carbonylation contributes to poor prognosis for cholangiocarcinoma.

Thanan R, Oikawa S, Yongvanit P, Hiraku Y, Ma N, Pinlaor S, Pairojkul C, Wongkham C, Sripa B, Khuntikeo N, Kawanishi S, Murata M.

Free Radic Biol Med. 2012 Apr 15;52(8):1465-72. doi: 10.1016/j.freeradbiomed.2012.01.018. Epub 2012 Feb 28.

PMID:
22377619
[PubMed - indexed for MEDLINE]
10.

Annexin A1: A new immunohistological marker of cholangiocarcinoma.

Hongsrichan N, Rucksaken R, Chamgramol Y, Pinlaor P, Techasen A, Yongvanit P, Khuntikeo N, Pairojkul C, Pinlaor S.

World J Gastroenterol. 2013 Apr 28;19(16):2456-65. doi: 10.3748/wjg.v19.i16.2456.

PMID:
23674846
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Cyclophilin A enhances cell proliferation and tumor growth of liver fluke-associated cholangiocarcinoma.

Obchoei S, Weakley SM, Wongkham S, Wongkham C, Sawanyawisuth K, Yao Q, Chen C.

Mol Cancer. 2011 Aug 26;10:102. doi: 10.1186/1476-4598-10-102.

PMID:
21871105
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Drug sensitivity and drug resistance profiles of human intrahepatic cholangiocarcinoma cell lines.

Tepsiri N, Chaturat L, Sripa B, Namwat W, Wongkham S, Bhudhisawasdi V, Tassaneeyakul W.

World J Gastroenterol. 2005 May 14;11(18):2748-53.

PMID:
15884115
[PubMed - indexed for MEDLINE]
Free Article
13.

[Clinical study of autoantibody spectrum against ovarian cancer associated antigens combined with CA(125) in detecting and monitoring ovarian cancer].

Yang ZJ, Yang G, Jiang YM, Ran YL, Yang ZH, Zhang W, Zhang JQ, Pan ZM, Li L.

Zhonghua Fu Chan Ke Za Zhi. 2011 Feb;46(2):113-8. Chinese.

PMID:
21426769
[PubMed - indexed for MEDLINE]
14.

Circulating anti-heat-shock-protein antibodies in normal pregnancy and preeclampsia.

Molvarec A, Derzsy Z, Kocsis J, Boze T, Nagy B, Balogh K, Makó V, Cervenak L, Mézes M, Karádi I, Prohászka Z, Rigó J Jr.

Cell Stress Chaperones. 2009 Sep;14(5):491-8. doi: 10.1007/s12192-009-0102-4. Epub 2009 Feb 11.

PMID:
19205928
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Mining the pre-diagnostic antibody repertoire of TgMMTV-neu mice to identify autoantibodies useful for the early detection of human breast cancer.

Mao J, Ladd J, Gad E, Rastetter L, Johnson MM, Marzbani E, Childs JS, Lu H, Dang Y, Broussard E, Stanton SE, Hanash SM, Disis ML.

J Transl Med. 2014 May 10;12:121. doi: 10.1186/1479-5876-12-121.

PMID:
24886063
[PubMed - in process]
Free PMC Article
16.

Patients with idiopathic pulmonary fibrosis with antibodies to heat shock protein 70 have poor prognoses.

Kahloon RA, Xue J, Bhargava A, Csizmadia E, Otterbein L, Kass DJ, Bon J, Soejima M, Levesque MC, Lindell KO, Gibson KF, Kaminski N, Banga G, Oddis CV, Pilewski JM, Sciurba FC, Donahoe M, Zhang Y, Duncan SR.

Am J Respir Crit Care Med. 2013 Apr 1;187(7):768-75. doi: 10.1164/rccm.201203-0506OC.

PMID:
23262513
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Serum IgG to heat shock proteins and Porphyromonas gingivalis antigens in diabetic patients with periodontitis.

Sims TJ, Lernmark A, Mancl LA, Schifferle RE, Page RC, Persson GR.

J Clin Periodontol. 2002 Jun;29(6):551-62.

PMID:
12296783
[PubMed - indexed for MEDLINE]
18.

Trefoil factors: tumor progression markers and mitogens via EGFR/MAPK activation in cholangiocarcinoma.

Kosriwong K, Menheniott TR, Giraud AS, Jearanaikoon P, Sripa B, Limpaiboon T.

World J Gastroenterol. 2011 Mar 28;17(12):1631-41. doi: 10.3748/wjg.v17.i12.1631.

PMID:
21472131
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Autoantibodies against p16 protein-derived peptides may be a potential biomarker for non-small cell lung cancer.

Zhang C, Ye L, Guan S, Jin S, Wang W, Sun S, Lee KH, Wei J, Liu B.

Tumour Biol. 2014 Mar;35(3):2047-51.

PMID:
24122232
[PubMed - indexed for MEDLINE]
20.

Platelet-derived growth factor may be a potential diagnostic and prognostic marker for cholangiocarcinoma.

Boonjaraspinyo S, Boonmars T, Wu Z, Loilome W, Sithithaworn P, Nagano I, Pinlaor S, Yongvanit P, Nielsen PS, Pairojkul C, Khuntikeo N.

Tumour Biol. 2012 Oct;33(5):1785-802. doi: 10.1007/s13277-012-0438-8. Epub 2012 Jun 26.

PMID:
22733151
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk